We are exploring direct cell reprogramming as a strategy to force cancer cells to become immunogenic again. It is specialized in R&D and in the use of direct cell reprogramming technologies for cancer immunotherapy. We aim to use our direct reprogramming discoveries to contribute to create a positive impact in patients life.We are committed to the challenge of making cancer immunotherapies available for every patient.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.